Boston Scientific Case Study

1037 Words3 Pages

Boston Scientific is currently working several strategies horizontal integration market penetration, market development, and product development based on their statements in their core values (About, 2015). While these strategies could be beneficial to the company, I do not think that the timing is right. Due to the poor economy and new changes, with effects unknown yet, choosing to grow could hurt them while the economy is not in the best stable condition. This is why I have suggested Boston Scientific to utilize the retrenching strategy in order to down size and rebuild.
Most of the goals that Boston Scientific will strive for through the retrenching process are obvious.
-Downsizing and regrouping - This will strengthen the trust of the …show more content…

For example even though there was a decrease in revenue from 2012 to 2013 there was still an increase in selling and general administrative expense (Boston Scientific, 2014). While at the same point you see a decrease year to year in research and development expenses (Boston Scientific, 2014). In my opinion this does not stand by what the companies mission statement suggest. If a company is truly trying to be innovative, would it not make more sense for them to keep their administrative budget the same so that it adjusted based on revenue. Rather than decreasing the very cost that should be helping the company continue to stay “on top” of the market to keep them …show more content…

So at first there may not be a huge difference. But this will free the company to focus on products that they know do well in the current market, and allow them to focus on getting that product out to market that are not currently held by them. Also the downsizing and regrouping will change the structure of executive staff, allowing for changes in compensation to be made. Though it is very important for current staff to feel important so they do not leave, the shareholders are important as well. By downsizing we can create a better budget around compensation so that it’s reflective around revenue. This will allow for a more fixed cost, when a company is able to control its compensation around the revenue they could be viewed as a better managed company, which should attract investors in the long run.
Currently the structure of Boston Scientific works down from the president, to the executive level then to a senior level (Boston Scientific, 2014). As far as the product division goes there is an executive for all three main product lines, then a senior for each sub division (Boston Scientific, 2014). This means that there are 7 seniors, three executives and one president who see over everything (Boston Scientific, 2014). Below I have listed some the salaries of these people within the executive

Open Document